# aTYR PHARMA INC: Form 8-K, filed May 29, 2024

- Company: [aTYR PHARMA INC](/companies/atyr.md) (CIK 1339970)
- Form: 8-K
- Filed: 2024-05-29
- Accepted by EDGAR: May 29, 2024, 16:03 ET
- Period: 2024-05-22
- Accession: 0000950170-24-065899
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1339970/000095017024065899/life-20240522.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1339970/000095017024065899/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.05: Item not in the standard list
- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1339970/000095017024065899/life-20240522.htm

Filed May 29, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-065899. Last ingested by Listed: Oct 27, 2026, 09:04 ET. No prices; not investment advice.